Renoprotective Effect of Metformin Against Renal Ischemic Reperfusion in Rats
World Small Animal Veterinary Association World Congress Proceedings, 2015
Y. Doustar1; N. Mehrdad2
1Pathobiology, Islamic Azad University-Tabriz Branch, Tabriz, Iran; 2Small Animal Internal Medicine, Islamic Azad University-Tabriz Branch, Tabriz, Iran

Heart failure following infection is one of the most important causes of death throughout the world. This study was undertaken to investigate the protective effects of metformin on apoptotic cell death of renal during experimental renal ischemia/reperfusion in (I/R) rats. Twenty-five male Wistar rats were randomly assigned into 5 groups of 5 animals each, including: 1. sham, 2. I/R, 3. low-dose metformin + I/R, 4. average dose metformin + I/R and 5. high-dose metformin + I/R. Renal ischemia was induced clamping the renal artery. After 30 min of ischemia, the clamps were taken off and the animals underwent 2 h reperfusion. Metformin (5, 10, and 20 µg/kg/min) was infused 15 min prior to reperfusion through the jugular vein in treatment groups. At the end of the experiment, the rats were euthanized and histological sections from renal tissue were prepared through the TUNEL method. Apoptotic cells were counted under light microscope. The data obtained were statistically analyzed using ANOVA. Differences were considered statistically significant at p ≤ 0.05. In group 2, ischemia/reperfusion caused occurrence of apoptotic cell death in renal tissue. There was a significant increase in the incidence rate of apoptosis of renal in comparison with group 1 (p ≤ 0.001). In groups 3–5, metformin (5, 10 and 20 µg/kg/min) caused significant decrease in the number of apoptotic cells in comparison with group 2 (p ≤ 0.05, p ≤ 0.01 and p ≤ 0.001, respectively). This study, therefore, suggests that metformin may be a useful agent for the prevention of ischemia/reperfusion-induced apoptotic cell death of renal in a dose-dependent manner in rats.


Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Y. Doustar
Islamic Azad University-Tabriz Branch
Tabriz, Iran

MAIN : Clinical Pharmacology & Toxicology : Renoprotective Effect of Metformin
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616


  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357